Avalere founder to head up JPMorgan healthcare innovation

Dan Mendelson, founder and former CEO of Avalere Health, will lead a new healthcare innovation group at JPMorgan Chase.

Advertisement

According to Mr. Mendelson’s tweet, work on the venture will commence April 26. The group is “staffing up” in Washington, D.C.

JPMorgan joined Amazon and Berkshire Hathaway in 2018 to form Haven with the aim to lower healthcare costs for their combined 1.2 million workers and serve as an industry disruptor. After a long period of silence, Haven disbanded in January

Mr. Mendelson founded Avalere Health in 2000. The company focuses on developing technology platforms and solutions to help healthcare organizations optimize their business.

 

More articles on payers:
UnitedHealth profit nears $5B in Q1
Lawsuit accuses BCBS of Massachusetts of systematically allowing overpayments
Ohio names 6 insurers to manage state’s $20B Medicaid contracts

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The hidden cost of lost clinical time and how leading health systems are responding

Friday, August 7
12:00 PM - 1:00 PM CDT

Presenters: Kassaundra McKnight-Young, Zebra TechnologiesGregory Carras, Zebra TechnologiesJennifer Gene, Levata

Advertisement

Next Up in Disruptors

Advertisement

Comments are closed.